Dr Delubac’s experiences span clinical diagnostics research, product development & lab operations, as well as synthetic biology.
He started his career at Counsyl, where he built the first fully automated, blood-to-data, robotic system for clinical-grade Next Generation Sequencing. He then joined Guardant Health where he supervised both process engineer at the company level and automation for sample processing, ensuring the company’s capabilities to scale efficiently, while preparing his functions for a FDA supervision. At Freenome, he led execution on the wetlab R&D, process engineering, automation, laboratory operations, supply chain, building next generation products for the unbiased discovery of cancer biomarkers using robotics and AI.
Eventually, he facilitated product development at the company level. Daniel served as COO at Xilis where he developed micro-organoids for oncology applications and President/COO of Chemify, a pioneering company offering digital chemistry infrastructure.
